The acquisition will allow Kensey Nash to further penetrate the regenerative medicine markets encompassing soft tissue surgical repair, orthopedics, sports medicine and neurosurgery. By 2015, the U.S. medical adhesive and sealant markets are projected to be over $1 billion, according to the release.
The company expects the acquisition to have a neutral impact on earnings because research and development spending on Nerites technology will be reallocated from other projects.
Read the Kensey Nash news release on the acquisition.
Read other coverage on orthopedic and spine device company acquisitions:
– Zimmer Finalizes Acquisition of Beijing Montagne Medical Device Co.
– DJO Acquires Elastic Therapy
– Stryker Acquires Gaymar Industries for $150M
